JPS6481A - H2-receptor antagonist compound - Google Patents
H2-receptor antagonist compoundInfo
- Publication number
- JPS6481A JPS6481A JP62336738A JP33673887A JPS6481A JP S6481 A JPS6481 A JP S6481A JP 62336738 A JP62336738 A JP 62336738A JP 33673887 A JP33673887 A JP 33673887A JP S6481 A JPS6481 A JP S6481A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- receptor antagonist
- expressed
- formula
- org
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003485 histamine H2 receptor antagonist Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 239000002585 base Substances 0.000 abstract 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 abstract 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 abstract 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 abstract 1
- NYROFODIKGNGFM-UHFFFAOYSA-N 2-(2-methylsulfanylethyl)guanidine Chemical compound CSCCNC(N)=N NYROFODIKGNGFM-UHFFFAOYSA-N 0.000 abstract 1
- 208000015877 Duodenal disease Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- 229960005261 aspartic acid Drugs 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- 235000004883 caffeic acid Nutrition 0.000 abstract 1
- 229940074360 caffeic acid Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001380 cimetidine Drugs 0.000 abstract 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 abstract 1
- 235000001785 ferulic acid Nutrition 0.000 abstract 1
- 229940114124 ferulic acid Drugs 0.000 abstract 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 abstract 1
- 229940074391 gallic acid Drugs 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 229960002989 glutamic acid Drugs 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT19009A/87 | 1987-01-07 | ||
| IT8719009A IT1215325B (it) | 1987-01-07 | 1987-01-07 | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0181A JPH0181A (ja) | 1989-01-05 |
| JPS6481A true JPS6481A (en) | 1989-01-05 |
Family
ID=11153818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62336738A Pending JPS6481A (en) | 1987-01-07 | 1987-12-28 | H2-receptor antagonist compound |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0277900A3 (ja) |
| JP (1) | JPS6481A (ja) |
| KR (1) | KR880009004A (ja) |
| IT (1) | IT1215325B (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888595A (en) * | 1986-11-13 | 1989-12-19 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Acquisition signal transmitter |
| US4954642A (en) * | 1985-11-15 | 1990-09-04 | Nippon Kayaku Kabushiki Kaisha | Forskolin compounds |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH679582A5 (ja) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4251449A (en) * | 1975-07-11 | 1981-02-17 | Clarence Schreur | Method of making a solid crystalline composition consisting essentially of calcium ascorbate |
| US4276219A (en) * | 1979-07-20 | 1981-06-30 | Pfizer Inc. | 5-Keto-L-ascorbic acid-5,5-dimethyl ketal, derivatives thereof and its use as an antioxidant and intermediate |
| EP0133493B1 (de) * | 1983-08-05 | 1989-01-25 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Verfahren zur Herstellung von Kohlenhydraten |
| CH674362A5 (en) * | 1986-08-05 | 1990-05-31 | Hasunor Ag | New ascorbate salts of H2 receptors antagonists |
-
1987
- 1987-01-07 IT IT8719009A patent/IT1215325B/it active
- 1987-12-27 KR KR1019870015139A patent/KR880009004A/ko not_active Application Discontinuation
- 1987-12-28 JP JP62336738A patent/JPS6481A/ja active Pending
-
1988
- 1988-01-05 EP EP88500002A patent/EP0277900A3/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954642A (en) * | 1985-11-15 | 1990-09-04 | Nippon Kayaku Kabushiki Kaisha | Forskolin compounds |
| US4888595A (en) * | 1986-11-13 | 1989-12-19 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Acquisition signal transmitter |
Also Published As
| Publication number | Publication date |
|---|---|
| IT1215325B (it) | 1990-02-08 |
| KR880009004A (ko) | 1988-09-13 |
| EP0277900A3 (en) | 1989-11-08 |
| EP0277900A2 (en) | 1988-08-10 |
| IT8719009A0 (it) | 1987-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2328780A1 (en) | Dihydropyrimidines | |
| ES8204739A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| JPS5653659A (en) | Blood platelet coagulation suppressing agent | |
| HU903963D0 (en) | Condensed heterocyclic compounds, their preparation and utilization | |
| WO1996016079A3 (en) | Alpha-ketoamide derivatives as cathepsin l inhibitor | |
| ES8606336A1 (es) | Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos | |
| CA2036905A1 (en) | Condensed thiazole compounds, their production and use | |
| ES8406193A1 (es) | Procedimiento para la preparacion de nuevas 1,4-dihidropiridinas sustituidas | |
| JPS6481A (en) | H2-receptor antagonist compound | |
| CA2226406A1 (en) | Novel pyridone carboxylic acid derivatives | |
| JPS55115892A (en) | 3-phosphonocephalosporanic acid derivative, its preparation, and medicine containing the same | |
| EP0248645A3 (en) | Cephalosporin compounds | |
| WO1997031016A3 (en) | New inhibitors of sh2-mediated processes | |
| JPS646261A (en) | 4-thioquinazoline derivative, its production and antiulcer agent containing said derivative as active component | |
| WO1991008737A3 (en) | Pharmacologically active amide carboxylate derivatives | |
| JPS574977A (en) | 2-guanidinothiazole derivative | |
| JPS6442475A (en) | Thiazolidine derivative | |
| JPS57183768A (en) | 4-methyl-5-(o-carboxyphenyl)carbamoylthiazole derivative and its preparation | |
| KR960014780B1 (en) | Dental plaque inhibitor composition and its preparation | |
| JPS5716855A (en) | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation | |
| JPS56142282A (en) | Penem-3-carboxylic acid derivative and its preparation | |
| JPS57140776A (en) | Preparation of 2-aminothiazol-4-yl-alpha-oximinoacetic acid derivative | |
| JPS55104266A (en) | Novel pyridone derivative | |
| JPS5772981A (en) | 1,8-naphthyridine derivative and its salt | |
| JPS5754177A (ja) | Chikanchiazoorujudotai |